By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Sigma-Aldrich announced last night that it has priced an aggregate principal amount of $300 million of senior notes due 2020 through a public offering.

The St. Louis-based research products and chemicals firm said that it would use proceeds from the offering for general corporate purposes.

The notes have a 10-year maturity, an issue price of 99.915 percent, and a fixed rate coupon of 3.375 percent, payable semi-annually.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.